| Literature DB >> 30789917 |
Nabarun Chakraborty1, Aarti Gautam2, Seid Muhie1, Stacy-Ann Miller3, Candace Moyler3, Marti Jett2, Rasha Hammamieh2.
Abstract
Initiation of treatment during the pre-symptomatic phase of Yersinia pestis (Y. pestis) infection is particularly critical. The rapid proliferation of Y. pestis typically couples with the manifestation of common flu-like early symptoms that often misguides the medical intervention. Our study used African green monkeys (AGM) that did not exhibit clear clinical symptoms for nearly two days after intranasal challenge with Y. pestis and succumbed within a day after showing the first signs of clinical symptoms. The lung, and mediastinal and submandibular lymph nodes (LN) accumulated significant Y. pestis colonization immediately after the intranasal challenge. Hence, organ-specific molecular investigations are deemed to be the key to elucidating mechanisms of the initial host response. Our previous study focused on the whole blood of AGM, and we found early perturbations in the ubiquitin-microtubule-mediated host defense. Altered expression of the genes present in ubiquitin and microtubule networks indicated an early suppression of these networks in the submandibular lymph nodes. In concert, the upstream toll-like receptor signaling and downstream NFκB signaling were inhibited at the multi-omics level. The inflammatory response was suppressed in the lungs, submandibular lymph nodes and mediastinal lymph nodes. We posited a causal chain of molecular mechanisms that indicated Y. pestis was probably able to impair host-mediated proteolysis activities and evade autophagosome capture by dysregulating both ubiquitin and microtubule networks in submandibular lymph nodes. Targeting these networks in a submandibular LN-specific and time-resolved fashion could be essential for development of the next generation therapeutics for pneumonic plague.Entities:
Mesh:
Substances:
Year: 2019 PMID: 30789917 PMCID: PMC6383991 DOI: 10.1371/journal.pone.0209592
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Fig 1Schematic of experimental design and corresponding organ collection sequence.
The timeline is not in scale. N: sample size; LN: Lymph node.
Fig 2Hierarchical clustering of the genes linked to ubiquitin and microtubules networks.
Genes clustered here showed alteration in at least one of the two early time points, 9 h and 12 h p.i. Ubiquitin-associated genes located in submandibular LN are shown in the left hierarchical tree. These genes linked to ubiquitination weren’t expressed in the lungs or mediastinal LN. All of these genes are listed in Table 3, which is in the same order as that in the figure. From the pool of genes linked to microtubule network, only those were mined that ranked in the primary and secondary tiers computed by GIH algorithm. Genes showing early (9 h or 12 h p.i.) alteration in expression are clustered in the right column. All of these genes are listed in Table 4 is in the same order as that in the figure. A scale depicting the range of color corresponding to the gene expression levels is shown at right.
Genes of interest from the ubiquitin network.
Genes showing early response for at least two early time points (9 h and 12 h p.i) are listed. Only the significant values (Log2 values) are reported.
| Gene name | Submandibular LN | Relevant to | |
|---|---|---|---|
| 9 h | 12 h | ||
| ANAPC10 | -1.8 | — | Ubiquitin ligase found susceptible to pathogen [ |
| PSMD10 | -1.8 | — | Involved with proteasome activity |
| USP8 | -1.8 | — | Immunomodulator of T cell development [ |
| HSP90AA1 | -1.9 | — | Encoded proteins, namely, Hsp70 and Hsp90, are markers of hyperthermia and collectively regulate NFκB-mediated inflammatory responses [ |
| PSMD14 | -2.0 | — | Involved with proteasome activity |
| BIRC2 | -2.5 | — | Alters the host response to pathogen [ |
| UBE2D2 | -2.5 | — | An integral part of proteasome system |
| USP12 | -2.0 | -2.6 | Regulator of T cell homeostasis and cell cycle progression [ |
| PSMA4 | -2.1 | -2.2 | Involved with proteasome activity |
| USP10 | -2.3 | -2.6 | Regulator of DNA damage [ |
| SKP2 | -2.3 | -2.4 | Provides a scaffold named SCF for ubiquitin-proteasome activity, immune response, apoptosis and cell signaling [ |
| DNAJC10 | -2.3 | -2.9 | Involved in recognizing and degrading misfolded proteins [ |
| USP3 | -1.8 | -2.0 | Suppression diminishes the reserve of the hematopoietic stem cell (HSC) and curtails the life span [ |
| UCHL5 | -2.6 | -3.3 | Suppression triggers apoptosis and proteotoxicity [ |
| USP44 | -2.8 | -3.3 | Regulator of DNA damage [ |
| HSPA13 | -2.9 | -3.8 | Involved in removal of denatured or incorrectly folded proteins [ |
| USP1 | -3.2 | -3.7 | Suppression causes the arrest of cellular replication and dysregulation of genome stability via controlling cellular senescence [ |
| PSMA1 | — | -3.1 | Involved with proteasome activity |
| SMURF2 | 2.1 | 2.5 | Promoter of proteasome-dependent protein degradation [ |
| ZBTB12 | 1.8 | 2.0 | Possibly acts as transcriptional regulation |
| CDC34 | — | 2.0 | Triggers processive ubiquitination via interlinking with SCF [ |
| PSMB6 | — | 2.9 | Early marker of sepsis onset [ |
| DNAJC16 | — | 2.9 | Regulator of apoptosis as encoding HSP40 [ |
| HSPB6 | — | 3.1 | Regulator of apoptosis and maintains protein homeostasis [ |
| B2M | — | 3.1 | Negative regulator of immune response [ |
| PSMB1 | — | 3.8 | Early marker of sepsis onset [ |
| HSPA12B | 2.3 | — | Regulator of apoptosis and neuroinflammation as a distinct family member of HSP40 [ |
| DNAJC5B | — | 5.6 | Regulator of apoptosis as encoding HSP40 [ |
| ODF1 | — | 5.1 | A candidate E3 ubiquitin ligase |
Genes of interest from the microtubule network.
Listed genes are from the pool ranked in the top tier of the Gene Interaction Hierarchy (GIH). Genes showing early response for at least two early time points (9 h and 12 h p.i.) are listed. Only the significant values (Log2 values) are reported.
| Gene | Submandibular LN | Mediastinal LN | Lungs | Relevance to present objective | |
|---|---|---|---|---|---|
| 9 h | 12 h | 12 h | 9 h | ||
| RANBP2 | -2.7 | -3.3 | -0.5 | — | Linked to phosphorylation of histone, an epigenetic marker of cell death [ |
| RACGAP1 | -3.8 | -3.4 | -0.5 | — | Associated with microtubule binding |
| CEP170 | -3.2 | -3.4 | — | — | Showed susceptibility to infection facilitating microtubule rearrangements [ |
| MAD2L1 | -5.0 | -4.5 | -0.8 | — | Critically associated with mitosis |
| HMGB1 | -2.1 | — | — | 2.1 | Modulates phagocytosis, inflammation and cell migration [ |
| TPM3 | -2.6 | — | — | 2.1 | Linked to apoptosis [ |
| CYLD | -2.4 | — | — | -1.6 | Checkpoint of necrosis [ |
| RAN | -2.8 | — | -0.6 | -2.2 | Protein and RNA translocator |
| SMARCE1 | -1.9 | — | — | — | Associated with proteostasis and ubiquitin-proteasome [ |
| HSP90AA1 | -1.9 | — | — | — | Promotes maturation, structural alteration and regulation of target proteins [ |
| EEF1A1 | -1.9 | — | — | — | Potentially inhibits viral growth and associated apoptosis [ |
| MYO6 | -2.0 | — | — | — | Contributes to phagocytosis along with microtubules [ |
| TLR4 | -2.0 | — | — | — | Controls energy homeostasis during stress [ |
| OFD1 | -2.1 | — | — | — | Controls centriole, a principal microtubule organizing centers [ |
| MAP2K4 | -2.1 | — | — | — | Directly associated with toll like receptor-mediated pattern recognition [ |
| TOP2B | -2.3 | — | — | — | Linked to DNA repair [ |
| SUMO1 | -2.3 | — | — | — | Undertakes many ubiquitin-linked functions including proteolysis [ |
| MAP3K1 | -2.5 | — | — | — | Selective activator of JNK-network-mediated apoptosis [ |
| PLCG2 | -2.5 | — | — | — | Linked to immunodeficiency [ |
| MAP3K7 | -2.6 | — | — | — | Recruits JNK, P38, AND NFκB under stress [ |
| KIF2C | -2.7 | — | — | — | Linked to microtubule assembly [ |
| NEK2 | -2.8 | — | — | — | Controls cell cycle propagation, cell survival and apoptosis [ |
| PRC1 | -2.9 | — | — | — | Controls microtubule architecture [ |
| CDK1 | -4.6 | — | -0.8 | — | Controls microtubule dynamics via regulating cell cycle transition and phosphorylation [ |
| WEE1 | -3.3 | — | — | — | Controls immunosurveillance [ |
| ITGA4 | -4.2 | — | — | — | Integral part of T-cell and B-cell based immune mechanism [ |
| TMEM17 | — | — | -0.4 | — | Regulates functions at ciliary transition zone [ |
| UBE3A | — | — | -0.5 | — | Associated with ubiquitin-proteasome pathway [ |
| CHEK1 | — | — | — | 2.0 | Activates DNA repair [ |
| MAP1B | — | — | — | 1.7 | Involved in microtubule assembly and dynamics [ |
| PARK2 | — | — | — | -1.5 | Presents structural fidelity to microtubules [ |
| ITGB1 | — | — | — | -1.7 | Supports microtubule stability [ |
| DBN1 | — | — | — | -1.7 | Crosslink actin and microtubule stability [ |
| PLAU | — | — | — | -1.8 | Maintain immune homeostasis [ |
| TNF | — | — | — | -1.9 | Encodes proinflammatory cytokine, which is critically linked to NFκB network |
| PTPRF | — | — | — | -1.9 | Associated with cell adhesion [ |
| IGF1R | — | — | — | -1.9 | Critically linked to apoptosis [ |
| RAB2A | — | — | — | -2.1 | Linked to phagocytosis and apoptosis [ |
| PSEN1 | — | — | — | -2.2 | Integral part for proper protein degradation through the autophagosome-lysosome system [ |
| CAV1 | — | — | — | -3.8 | Inhibits the depolymerization of microtubule [ |
The list of genes assayed for validation using QuantiGene Plex platform.
The high throughput array data and BioPlex/qPCR data are presented in a log2 (fold change).Those instances, where the regulations measured by array and qPCR results are in opposite directions were in italics. S6 Fig depicts the bar plots of qPCR results.
| Time Course → | 9h | 12h | 24h | 32h | 42h | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gene Name | Array | qPCR | Array | qPCR | Array | qPCR | Array | qPCR | Array | qPCR | Gene Functions | |
| -2.50 | -6.20 | — | — | -2.30 | -6.30 | -3.00 | -0.95 | — | — | Provides neuroprotection | ||
| -1.61 | -0.96 | — | — | -1.61 | -1.80 | -2.01 | -1.06 | — | — | Checkpoint of necrosis [ | ||
| 1.80 | 1.30 | -1.91 | -1.20 | 1.61 | 0.83 | — | — | — | — | Linked to proteasomal degradation | ||
| -2.02 | -0.27 | — | — | -2.97 | -0.73 | -1.90 | -1.31 | Regulator of T cell homeostasis and cell cycle progression [ | ||||
| -2.26 | -0.25 | -2.6 | -0.60 | -2.11 | 0.82 | -2.43 | -0.93 | -2.04 | -2.47 | Regulator of DNA damage [ | ||
| -2.28 | -0.55 | -2.42 | -0.11 | -2.13 | 1.01 | -2.87 | -1.17 | -1.91 | -2.95 | Provides a scaffold named SCF for ubiquitin-proteasome activity, immune response, apoptosis and cell signaling [ | ||
| -2.13 | -0.90 | -2.2 | -0.40 | -2.47 | -0.93 | -2.81 | -0.44 | -2.23 | -3.30 | Involved with proteasome activity | ||
Predicted levels of activation of different biological functions.
Upward arrows and downward arrows represent the activation and inhibition, respectively. The ‘x’ represents no change.
| Bacterial infection | ↑ | X | X | ↑ | ↑ |
| Ubiquitin signal | ↓ | X | X | ↓ | ↓ |
| Microtubule dynamics | ↓ | ↓ | ↓ | ↓ | ↓ |
| Organization of microtubule | ↓ | ↓ | ↓ | ↓ | ↓ |
| IκB kinase/NFκB cascade | ↓ | X | ↓ | ↓ | ↓ |
| TLR signaling | ↓ | X | X | ↓ | ↓ |
| Apoptosis | ↑ | ↑ | X | ↑ | ↑ |
| Inflammatory response | ↓ | ↓ | ↓ | ↓ | ↓ |
| Bacterial infection | X | X | X | X | X |
| Ubiquitin signal | X | X | X | X | X |
| Microtubule dynamics | X | X | X | X | X |
| Organization of microtubule | X | X | X | X | X |
| IκB kinase/NFκB cascade | X | X | X | ↓ | X |
| TLR signaling | X | X | X | X | X |
| Apoptosis | ↑ | ↑ | ↑ | X | ↑ |
| Inflammatory response | ↓ | ↓ | ↓ | ↓ | ↑ |
| Bacterial infection | X | X | X | ↑ | X |
| Ubiquitin signal | X | X | X | X | X |
| Microtubule dynamics | X | ↓ | ↓ | ↓ | ↓ |
| Organization of microtubule | X | ↓ | ↓ | ↓ | ↓ |
| IκB kinase/NFκB cascade | X | X | X | ↓ | X |
| TLR signaling | X | X | X | ↓ | X |
| Apoptosis | ↑ | ↑ | X | ↑ | ↑ |
| Inflammatory response | ↓ | ↓ | ↓ | ↓ | ↓ |
Fig 3Time and tissue–specific abundance of candidate proteins.
(A) Ubiquitin abundance in submandibular LN, Mediastinal LN and Lungs. (B) Microtubule associated protein (MAP) abundance in submandibular LN, Mediastinal LN and Lungs. (C) NFκB abundance in submandibular LN, Mediastinal LN and Lungs. The dotted line parallel to x-axis depicts the cut-off at fold change ±1.5. GraphPad Prism was used for visualization and calculation of the statistical significance using Welch’s t-test (# p<0.1; * p< 0.05; ** p<0.01). LN: Lymph node.
Fig 4A pictorial representation of the cluster of networks that became susceptible to Y. pestis at 9 h p.i.
The box adjacent to the gene/function represents the corresponding predicted level of regulations in submandibular LN, lungs and mediastinal LN, respectively at 9 h p.i. The predicted regulations of ubiquitin, microtubules and NFκB were confirmed by investigating the time and tissue specific abundance of candidate proteins. The green upward arrow and red downward arrow represent the activation and inhibition, respectively. The ‘x’ stands for no change.